163 related articles for article (PubMed ID: 26330446)
21. The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia.
Bastos-Leite AJ; van der Flier WM; van Straaten EC; Staekenborg SS; Scheltens P; Barkhof F
Stroke; 2007 Dec; 38(12):3182-5. PubMed ID: 17962598
[TBL] [Abstract][Full Text] [Related]
22. Haemoglobin, magnetic resonance imaging markers and cognition: a subsample of population-based study.
Tan B; Venketasubramanian N; Vrooman H; Cheng CY; Wong TY; Chen C; Hilal S
Alzheimers Res Ther; 2018 Nov; 10(1):114. PubMed ID: 30400991
[TBL] [Abstract][Full Text] [Related]
23. Serum Brevican as a Biomarker of Cerebrovascular Disease in an Elderly Cognitively Impaired Cohort.
Chia RSL; Minta K; Wu LY; Salai KHT; Chai YL; Hilal S; Venketasubramanian N; Chen CP; Chong JR; Lai MKP
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254675
[TBL] [Abstract][Full Text] [Related]
24. The Effects of Mean of Visit-to-Visit Blood Pressure on Incident Brain Vascular Lesions and Functional-Cognitive Decline.
Gyanwali B; Cai CXT; Chen C; Vrooman H; Tan CS; Hilal S
J Alzheimers Dis; 2021; 82(2):561-573. PubMed ID: 34057087
[TBL] [Abstract][Full Text] [Related]
25. The balance between cognitive reserve and brain imaging biomarkers of cerebrovascular and Alzheimer's diseases.
Murray AD; Staff RT; McNeil CJ; Salarirad S; Ahearn TS; Mustafa N; Whalley LJ
Brain; 2011 Dec; 134(Pt 12):3687-96. PubMed ID: 22102649
[TBL] [Abstract][Full Text] [Related]
26. Serum Hepatocyte Growth Factor Is Associated with Small Vessel Disease in Alzheimer's Dementia.
Zhu Y; Hilal S; Chai YL; Ikram MK; Venketasubramanian N; Chen CP; Lai MKP
Front Aging Neurosci; 2018; 10():8. PubMed ID: 29410622
[No Abstract] [Full Text] [Related]
27. Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy.
Staekenborg SS; Koedam EL; Henneman WJ; Stokman P; Barkhof F; Scheltens P; van der Flier WM
Stroke; 2009 Apr; 40(4):1269-74. PubMed ID: 19228848
[TBL] [Abstract][Full Text] [Related]
28. Neuroimaging and neuropathology indices of cerebrovascular disease burden: A systematic review.
Paradise MB; Shepherd CE; Wen W; Sachdev PS
Neurology; 2018 Aug; 91(7):310-320. PubMed ID: 30021917
[TBL] [Abstract][Full Text] [Related]
29. Markers of cardiac dysfunction in cognitive impairment and dementia.
Hilal S; Chai YL; Ikram MK; Elangovan S; Yeow TB; Xin X; Chong JY; Venketasubramanian N; Richards AM; Chong JPC; Lai MKP; Chen C
Medicine (Baltimore); 2015 Jan; 94(1):e297. PubMed ID: 25569645
[TBL] [Abstract][Full Text] [Related]
30. Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease.
Zhu Y; Chai YL; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CP; Lai MK
Alzheimers Dement (Amst); 2017; 7():41-47. PubMed ID: 28239640
[TBL] [Abstract][Full Text] [Related]
31. Cerebral small-vessel disease and decline in information processing speed, executive function and memory.
Prins ND; van Dijk EJ; den Heijer T; Vermeer SE; Jolles J; Koudstaal PJ; Hofman A; Breteler MM
Brain; 2005 Sep; 128(Pt 9):2034-41. PubMed ID: 15947059
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker.
Patel B; Markus HS
Int J Stroke; 2011 Feb; 6(1):47-59. PubMed ID: 21205241
[TBL] [Abstract][Full Text] [Related]
33. Subclinical cerebrovascular disease inversely associates with learning ability: The NOMAS.
Glazer H; Dong C; Yoshita M; Rundek T; Elkind MS; Sacco RL; DeCarli C; Stern Y; Wright CB
Neurology; 2015 Jun; 84(23):2362-7. PubMed ID: 26002489
[TBL] [Abstract][Full Text] [Related]
34. Basal ganglia cerebral microbleeds and global cognitive function: the Kashima Scan Study.
Yakushiji Y; Noguchi T; Charidimou A; Eriguchi M; Nishihara M; Hara M; Nanri Y; Horikawa E; Nishiyama M; Werring DJ; Hara H
J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):431-9. PubMed ID: 25516488
[TBL] [Abstract][Full Text] [Related]
35. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population.
Henneman WJ; Sluimer JD; Cordonnier C; Baak MM; Scheltens P; Barkhof F; van der Flier WM
Stroke; 2009 Feb; 40(2):492-8. PubMed ID: 19109551
[TBL] [Abstract][Full Text] [Related]
36. The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES).
Chen CL; Ikram K; Anqi Q; Yin WT; Chen A; Venketasubramanian N;
Cerebrovasc Dis; 2013; 35 Suppl 1():23-9. PubMed ID: 23548916
[TBL] [Abstract][Full Text] [Related]
37. Abnormal functional connectivity in patients with vascular cognitive impairment, no dementia: a resting-state functional magnetic resonance imaging study.
Sun YW; Qin LD; Zhou Y; Xu Q; Qian LJ; Tao J; Xu JR
Behav Brain Res; 2011 Oct; 223(2):388-94. PubMed ID: 21605598
[TBL] [Abstract][Full Text] [Related]
38. Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history.
Dufouil C; Godin O; Chalmers J; Coskun O; MacMahon S; Tzourio-Mazoyer N; Bousser MG; Anderson C; Mazoyer B; Tzourio C;
Stroke; 2009 Jun; 40(6):2219-21. PubMed ID: 19390070
[TBL] [Abstract][Full Text] [Related]
39. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
[TBL] [Abstract][Full Text] [Related]
40. Association between cortical volume loss and cognitive impairments in essential tremor.
Bhalsing KS; Upadhyay N; Kumar KJ; Saini J; Yadav R; Gupta AK; Pal PK
Eur J Neurol; 2014 Jun; 21(6):874-83. PubMed ID: 24612409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
